Thursday's Health Winners & Losers

05/31/07 - 03:36 PM EDT

Elizabeth Trotta

Several health-care stocks moved higher on Canadian, European and U.S. regulatory action Thursday, and one of the biggest moves came from Dendreon(DNDN Quote), which recently was climbing 33%.

The Food and Drug Administration confirmed it would accept either a positive interim or final analysis of survival from Dendreon's latest trial to approve its prostate-cancer vaccine Provenge. Shares were up $2.48 to $9.23.

Avanir Pharmaceuticals(AVNR Quote) got the FDA's approval to market a new orally disintegrating tablet formulation of its antipsychotic drug clozapine, marketed as FazaClo. Previously the drug was available in 25-mg and 100-mg dosage strengths in blister packaging, but the company will now additionally market bottle packaging and a 12.5-mg dosage strength.

Avanir said the bottles will be available in pharmacies shortly and it expects health care professionals and patients will find them more convenient. Shares were up 10%, or 33 cents, to $3.55 midday, after rising 16 percent to $3.70 in early trading.

Encysive Pharmaceuticals (ENCY Quote) was higher by 45 cents, or 12.3%, at $4.03 on an announcement late Wednesday that the Canadian health authority approved Thelin for treatment of pulmonary artery hypertension in that country.

< Previous
1 2
Your Recent Quotes: Quote Up0 | Quote Down0
 
Dow S&P 500 NASDAQ
Oil*
61.21
8,359.49
905.84
1,799.73
10 Yr
3.45%
27.81
4.79
6.52
+0.33%
+0.53%
+0.36%
Data delayed 20 min
Get Jim Cramer's Free Newsletter

The Daily Booyah!
Get your daily dose of Cramer in your inbox.
Submit
We respect your privacy.

Premium Stock Ideas
Access Action Alerts Plus to find out Cramer's latest picks now!

Brokerage Partners